Global Bioprocess Technology Market To Generate Revenue Of USD 79 Billion By 2028

The global bioprocess technology market size was worth over USD 18 billion in 2021 and is predicted to grow to around USD 79 billion by 2028 with a compound annual growth rate (CAGR) of roughly 15% between 2022 and 2028.

Bioprocess technology or engineering is what puts biotechnology to work and is a discipline that deals with the designing and development of processes or equipment that aid the production of food, agriculture, nutraceuticals, polymers, and papers with the help of biological materials along with treated wastewater. It is a mixture of biology, mathematics, and industrial design and involves various technologies like bioreactors designing, detailed analysis of fermenters, etc. Bioprocess technology also deals with the study of biotechnological processes that can be used in industries for the production of biological products at a large scale by optimizing the end-product yield along with the improved quality of the output.

Bioprocess technology generally involves 2 main steps: upstream bioprocessing and downstream bioprocessing. Upstream processing is the initial part of bioprocessing which includes steps like identification of the organism to be produced, optimization of conditions in which the process will be conducted, followed by the cultivation of the organism. Downstream consists of the end parts of the process and involves the purification of the cell or organism created at the end of the previous step. Post purification, the cell can be used to create the desired product following quality and safety standards.

Covid-19 impacted the global market growth significantly since, during the peak of the pandemic, government authorities and private players were investing heavily in the bioprocess technology for research and development of vaccines against the virus.

The global bioprocess technology market is expected to grow owing to the increasing geriatric population and the resulting number of medical cases across the globe. As per official reports, more than 23% of the world population will have crossed over 65 years of age by 2050. Since the elderly population is the most vulnerable to diseases that are not yet prescribed with effective cure treatment like cancer, diabetes, hypertension, etc. it may aid global market expansion since bioprocess technology is used extensively by the pharmaceutical and healthcare sector. Given the huge number of applications bioprocess technologies have proven to have in almost all sectors, leading market players are investing in the development of advanced technologies that can be used in bioprocesses where the emphasis is more on research and production of next-generation devices which may augment the global market growth since it will aid the increase in the global consumer database.

The stringent government regulations may restrain the global market growth. However, the strategic decisions by market players may provide growth opportunities for global market expansion. Nonetheless, the high cost of bioprocess technology may challenge global market growth in the next few years.

The global bioprocess technology market is segmented by type, application, end-user, and region.

By type, the global market is segmented into cell expansion, cell culture, cell line development, flow cytometry, and virus infiltration. Cell culture bioprocessing may dominate the global market due to increased research and production of therapeutic proteins in the healthcare sector.

By application, the global market segments are specialty products, environment management aid, biopharmaceuticals and industrial chemicals. Due to the rise in the number of infectious as well as chronic diseases, the global market is expected to be led by the pharmaceutical sector. The sector contributed over USD 400 billion in 2021 and is expected to grow even more in the next few years.

Based on end-users, the global market is divided into medical institutions, research laboratories & centers, and hospitals. The global highest revenue may generate the highest revenue from the research laboratories owing to growing investments towards research on medicines, diseases, and other future biomedical problems.

The global bioprocess technology is expected to be dominated by North America mostly due to the presence of key players in the regions like Canada, the USA, and Mexico. The healthcare and pharmaceutical sector of these regions are working together in strategic directions to penetrate the regional user group and expand their consumer database. Pharmaceutical organizations and bioprocess technology manufacturers are adopting tactical methods to inflate their global footprint which may propel regional market growth.

Europe is expected to follow North America in generating high revenue. Germany is expected to lead the regional growth with the contribution of over 28% of the total regional market which is expected to be driven by increasing efforts in contamination prevention, wastage reduction, and higher demand for biopharmaceuticals.

The global bioprocess technology market is driven by players like Lonza, GE Healthcare (General Electric Company), Thermo Fisher Scientific, IncSartorius AG, Eppendorf AG, Dickinson and Company, Becton, Siemens Healthineers, Nova Biomedical, Advanced Instruments, F. Hoffmann-La Roche Ltd., and Danaher Corporation.

Recent Development:

• In June 2020, New GSv9 TM Media and Feeds was launched by Lonza. The product maximized yield and batch-to-batch consistency thus supporting and augmenting recombinant protein production. GSv9 ™ is a chemically defined media and feeds platform which is developed to enhance the performance of the GS Gene Expression System.
• In March 2020, Danaher Corporation completed its acquisition of the Biopharma Business from GE Company’s Life Sciences division. The business was renamed Cytiva, as a part of the Danaher Group and continues to act as a standalone company with the Life Sciences division of Danaher, thus aiding the group in expanding its portfolio in bioprocessing and technology.

Browse the full “Global Bioprocess Technology Market By Application (Specialty products, Environment Management Aid, Biopharmaceuticals, and Industrial Chemicals), By Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, and Virus Infiltration), By End-User (Medical Institutions, Research Laboratories & Centers, and Hospitals), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/bioprocess-technology-market

The global bioprocess technology market is segmented as follows:

By Application

• Specialty products
• Environment Management Aid
• Biopharmaceuticals
• Industrial chemicals

By Type

• Cell Expansion
• Cell Culture
• Cell Line Development
• Flow Cytometry
• Virus Infiltration

By End-User

• Medical Institutions
• Research Laboratories & Centers
• Hospitals

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com